治疗方案-话题@MedSci

#治疗方案#

313篇内容 | 2742人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1904929, encodeId=2e2d19049299e, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Radiother Oncol: 山东大学研究者发现缺氧诱导CDUPRT/5-FC基因治疗方案能特异性靶向缺氧肿瘤细胞, objectType=article, longId=18834, objectId=af961883421, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af961883421, replyNumber=0, likeNumber=33, createdTime=2013-09-17, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af961883421, moduleTitle=Radiother Oncol: 山东大学研究者发现缺氧诱导CDUPRT/5-FC基因治疗方案能特异性靶向缺氧肿瘤细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af961883421)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904920, encodeId=e6a71904920f3, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=CA Cancer J Clin：Oncotype DX HER2检查结果不能作为乳腺癌治疗方案的决策标准, objectType=article, longId=13717, objectId=e27d13e1792, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27d13e1792, replyNumber=0, likeNumber=35, createdTime=2013-09-27, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27d13e1792, moduleTitle=CA Cancer J Clin：Oncotype DX HER2检查结果不能作为乳腺癌治疗方案的决策标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e27d13e1792)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904925, encodeId=5ec81904925fa, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Radiother Oncol：放化疗应成为N1小细胞食管癌的最佳治疗方案, objectType=article, longId=18086, objectId=9dba1808679, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dba1808679, replyNumber=0, likeNumber=41, createdTime=2013-07-04, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dba1808679, moduleTitle=Radiother Oncol：放化疗应成为N1小细胞食管癌的最佳治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dba1808679)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904914, encodeId=89fd1904914b6, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JNCI：急性淋巴细胞白血病患儿治疗方案损害认知功能, objectType=article, longId=9549, objectId=cc519549d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc519549d1, replyNumber=0, likeNumber=39, createdTime=2013-04-01, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc519549d1, moduleTitle=JNCI：急性淋巴细胞白血病患儿治疗方案损害认知功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc519549d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904915, encodeId=bc2d1904915b4, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Oncol：III期临床研究证实晚期鼻咽癌标准治疗方案未使患者获益, objectType=article, longId=10558, objectId=8e311055832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e311055832, replyNumber=0, likeNumber=35, createdTime=2013-07-07, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e311055832, moduleTitle=Lancet Oncol：III期临床研究证实晚期鼻咽癌标准治疗方案未使患者获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e311055832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904917, encodeId=3139190491e8b, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JCO:ABVD仍是进展期霍奇金淋巴瘤的标准治疗方案, objectType=article, longId=12101, objectId=dd1912101f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd1912101f8, replyNumber=0, likeNumber=53, createdTime=2013-07-20, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd1912101f8, moduleTitle=JCO:ABVD仍是进展期霍奇金淋巴瘤的标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd1912101f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904916, encodeId=7f661904916f5, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=标准治疗方案中加入阿瓦斯汀可显著延长初诊侵袭性胶质瘤的无进展生存期（AVAglio研究）, objectType=article, longId=11325, objectId=b81e1132569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b81e1132569, replyNumber=0, likeNumber=45, createdTime=2013-06-22, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b81e1132569, moduleTitle=标准治疗方案中加入阿瓦斯汀可显著延长初诊侵袭性胶质瘤的无进展生存期（AVAglio研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b81e1132569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904919, encodeId=8e9f19049196f, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=FDA：替拉瑞韦联合治疗方案或致严重皮肤反应, objectType=article, longId=13662, objectId=739013662af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=739013662af, replyNumber=0, likeNumber=32, createdTime=2012-12-28, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=739013662af, moduleTitle=FDA：替拉瑞韦联合治疗方案或致严重皮肤反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=739013662af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904913, encodeId=05ed190491367, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=刘云鹏教授：晚期胰腺癌的治疗方案探索, objectType=article, longId=9354, objectId=edb393549d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edb393549d, replyNumber=0, likeNumber=38, createdTime=2013-02-21, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edb393549d, moduleTitle=刘云鹏教授：晚期胰腺癌的治疗方案探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edb393549d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904911, encodeId=2c431904911b4, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JCO：NSCLC标准治疗方案不应添加沙利度胺, objectType=article, longId=4084, objectId=cb3b40844d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb3b40844d, replyNumber=0, likeNumber=51, createdTime=2012-10-11, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb3b40844d, moduleTitle=JCO：NSCLC标准治疗方案不应添加沙利度胺, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb3b40844d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904912, encodeId=d34519049120e, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Nature reviews：聚焦癌症全新治疗方案, objectType=article, longId=5007, objectId=5872500e3e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5872500e3e, replyNumber=0, likeNumber=30, createdTime=2012-10-23, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5872500e3e, moduleTitle=Nature reviews：聚焦癌症全新治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5872500e3e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904910, encodeId=e8d5190491044, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=慢性淋巴细胞白血病新初始治疗方案研究, objectType=article, longId=2794, objectId=762b2e9464, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=762b2e9464, replyNumber=0, likeNumber=39, createdTime=2011-08-21, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=762b2e9464, moduleTitle=慢性淋巴细胞白血病新初始治疗方案研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=762b2e9464)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1904909, encodeId=492119049093a, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=AACE公布全新糖尿病综合治疗方案指(附下载), objectType=article, longId=2546, objectId=907b2546b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=907b2546b4, replyNumber=0, likeNumber=30, createdTime=2011-08-23, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=907b2546b4, moduleTitle=AACE公布全新糖尿病综合治疗方案指(附下载), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=907b2546b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗方案

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Radiother Oncol: 山东大学研究者发现缺氧诱导CDUPRT/5-FC基因治疗方案能特异性靶向缺氧肿瘤细胞

2013-09-17

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

CA Cancer J Clin：Oncotype DX HER2检查结果不能作为乳腺癌治疗方案的决策标准

2013-09-27

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Radiother Oncol：放化疗应成为N1小细胞食管癌的最佳治疗方案

2013-07-04

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JNCI：急性淋巴细胞白血病患儿治疗方案损害认知功能

2013-04-01

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Oncol：III期临床研究证实晚期鼻咽癌标准治疗方案未使患者获益

2013-07-07

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JCO:ABVD仍是进展期霍奇金淋巴瘤的标准治疗方案

2013-07-20

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

标准治疗方案中加入阿瓦斯汀可显著延长初诊侵袭性胶质瘤的无进展生存期（AVAglio研究）

2013-06-22

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

FDA：替拉瑞韦联合治疗方案或致严重皮肤反应

2012-12-28

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

刘云鹏教授：晚期胰腺癌的治疗方案探索

2013-02-21

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JCO：NSCLC标准治疗方案不应添加沙利度胺

2012-10-11

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Nature reviews：聚焦癌症全新治疗方案

2012-10-23

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

慢性淋巴细胞白血病新初始治疗方案研究

2011-08-21

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

AACE公布全新糖尿病综合治疗方案指(附下载)

2011-08-23

科室
- - 订阅+
  - 更多科室
工具
服务